Cargando…

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications

The commensal microbiota is involved in a variety of diseases. Our group has noticed that patients with Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) often present with persistent inflammation of the ocular surface, even in the chronic stage, and that this inflammation is exacerbat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueta, Mayumi, Hosomi, Koji, Park, Jonguk, Mizuguchi, Kenji, Sotozono, Chie, Kinoshita, Shigeru, Kunisawa, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640524/ https://www.ncbi.nlm.nih.gov/pubmed/34869055 http://dx.doi.org/10.3389/fcimb.2021.741654

Ejemplares similares

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Sotozono, Chie, et al.
Publicado: (2021)

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
por: Ueta, Mayumi, et al.
Publicado: (2008)

Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis
por: Yoshikawa, Yamato, et al.
Publicado: (2020)

Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2017)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals
por: Ueta, Mayumi, et al.
Publicado: (2019)

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis
por: Kinoshita, Fumie, et al.
Publicado: (2021)

HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
por: Ueta, Mayumi, et al.
Publicado: (2012)

Medication tendencies for inducing severe ocular surface symptoms in Japanese Stevens-Johnson Syndrome / toxic epidermal necrolysis patients
por: Saito, Yoshiro, et al.
Publicado: (2014)

Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome
por: Aziza, Yulia, et al.
Publicado: (2022)

Strong association between hla-a*02:06 and acetaminophen-related stevens-johnson syndrome with severe mucosal involvements in the Japanese
por: Ueta, Mayumi, et al.
Publicado: (2014)

HLA association with antipyretic analgesics-induced Stevens-Johnson Syndrome / toxic epidermal necrolysis with severe ocular surface complications in japanese patients
por: Nakamura, Ryosuke, et al.
Publicado: (2014)

The Ocular Microbiome in Stevens-Johnson Syndrome
por: Kittipibul, Thanachaporn, et al.
Publicado: (2021)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens–Johnson Syndrome Cases
por: Yoshikawa, Yamato, et al.
Publicado: (2023)

HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications
por: Ueta, Mayumi, et al.
Publicado: (2015)

Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2019)

Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population
por: Kannabiran, Chitra, et al.
Publicado: (2017)

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing
por: Kawai, Yosuke, et al.
Publicado: (2021)

Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens–Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2020)

In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients
por: Isogai, Hideto, et al.
Publicado: (2013)

Human leukocyte antigen B*0702 is protective against ocular Stevens–Johnson syndrome/toxic epidermal necrolysis in the UK population
por: Butt, Gibran F., et al.
Publicado: (2021)

Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
por: Nakatani, Ken, et al.
Publicado: (2019)

Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions
por: Ueta, Mayumi
Publicado: (2016)

Limbal-Rigid Contact Lens Wear for the Treatment of Ocular Surface Disorders: A Review
por: Aziza, Yulia, et al.
Publicado: (2022)

Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders
por: Ueta, Mayumi, et al.
Publicado: (2011)

Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects
por: Kittipibul, Thanachaporn, et al.
Publicado: (2020)

Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications
por: Ueta, Mayumi, et al.
Publicado: (2014)

Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013)

Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study
por: Ueta, Mayumi, et al.
Publicado: (2012)

Study of Ocular Manifestations of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Abrol, Arundha, et al.
Publicado: (2020)

Association of IKZF1 SNPs in cold medicine-related Stevens–Johnson syndrome in Thailand
por: Chantaren, Patchima, et al.
Publicado: (2019)

HLA genotypes and cold medicine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis
por: Tangamornsuksan, Wimonchat, et al.
Publicado: (2020)

Disturbances in the ocular surface microbiome by perioperative antimicrobial eye drops
por: Hotta, Fumika, et al.
Publicado: (2023)

Immunosuppressive therapy in inflammatory ocular surface disease post Steven Johnson syndrome
por: Balkrishnan, C, et al.
Publicado: (2011)

Prevalence of Chronic Ocular Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Zyl, Lourens Van, et al.
Publicado: (2014)

Chronic ocular sequelae in Stevens–Johnson syndrome: a genetic association study
por: Sangwan, Sushil K., et al.
Publicado: (2022)

Comparison of the Ocular Microbiomes of Dry Eye Patients With and Without Autoimmune Disease
por: Qi, Yun, et al.
Publicado: (2021)

Metagenomic profiling of ocular surface microbiome changes in Demodex blepharitis patients
por: Fu, Yana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imim06i6o5u55qafvkotbjn26r